CRMA-1001

· nChroma Bio

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CRMA-1001, covering 2026-01-29 to 2026-01-29. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1/2, Open-Label, Single and Multiple Ascending Dose Study of CRMA-1001 in Adults With Chronic Hepatitis B [Phase 1, Phase 2]

See pricing